These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 19712765

  • 1. Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.
    López A, van der Lubbe N, Sánchez-Palomino S, Arnedo M, Nomdedeu M, Castro P, Guilà M, Maleno MJ, García F, Gallart T, Gatell JM, Plana M.
    Vaccine; 2009 Oct 19; 27(44):6166-78. PubMed ID: 19712765
    [Abstract] [Full Text] [Related]

  • 2. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E, Vlieghe E, Vekemans M, Van Tendeloo VF, Van De Velde A, Smits E, Anguille S, Cools N, Goossens H, Mertens L, De Haes W, Wong J, Florence E, Vanham G, Berneman ZN.
    AIDS; 2012 Feb 20; 26(4):F1-12. PubMed ID: 22156965
    [Abstract] [Full Text] [Related]

  • 3. CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses.
    Arrode G, Finke JS, Zebroski H, Siegal FP, Steinman RM.
    Eur J Immunol; 2005 Jan 20; 35(1):159-70. PubMed ID: 15580653
    [Abstract] [Full Text] [Related]

  • 4. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM, Lawrence J, Schapiro JM, Altman JD, Winters MA, Crompton M, Loi M, Kundu SK, Davis MM, Merigan TC.
    J Immunol; 1999 Feb 01; 162(3):1780-8. PubMed ID: 9973442
    [Abstract] [Full Text] [Related]

  • 5. Identification and characterization of HIV-1 CD8+ T cell escape variants with impaired fitness.
    Sanchez-Merino V, Farrow MA, Brewster F, Somasundaran M, Luzuriaga K.
    J Infect Dis; 2008 Jan 15; 197(2):300-8. PubMed ID: 18177249
    [Abstract] [Full Text] [Related]

  • 6. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
    Gillespie GM, Pinheiro S, Sayeid-Al-Jamee M, Alabi A, Kaye S, Sabally S, Sarge-Njie R, Njai H, Joof K, Jaye A, Whittle H, Rowland-Jones S, Dorrell L.
    Eur J Immunol; 2005 May 15; 35(5):1445-53. PubMed ID: 15832290
    [Abstract] [Full Text] [Related]

  • 7. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
    Jansen CA, Kostense S, Vandenberghe K, Nanlohy NM, De Cuyper IM, Piriou E, Manting EH, Miedema F, van Baarle D.
    Eur J Immunol; 2005 Jan 15; 35(1):150-8. PubMed ID: 15593302
    [Abstract] [Full Text] [Related]

  • 8. Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine.
    Cobb A, Roberts LK, Palucka AK, Mead H, Montes M, Ranganathan R, Burkeholder S, Finholt JP, Blankenship D, King B, Sloan L, Harrod AC, Lévy Y, Banchereau J.
    J Immunol Methods; 2011 Feb 28; 365(1-2):27-37. PubMed ID: 21093448
    [Abstract] [Full Text] [Related]

  • 9. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM.
    Eur J Immunol; 2008 Jun 28; 38(6):1548-58. PubMed ID: 18421792
    [Abstract] [Full Text] [Related]

  • 10. Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial.
    Ide F, Nakamura T, Tomizawa M, Kawana-Tachikawa A, Odawara T, Hosoya N, Iwamoto A.
    J Med Virol; 2006 Jun 28; 78(6):711-8. PubMed ID: 16628588
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses.
    Sáez-Cirión A, Sinet M, Shin SY, Urrutia A, Versmisse P, Lacabaratz C, Boufassa F, Avettand-Fènoël V, Rouzioux C, Delfraissy JF, Barré-Sinoussi F, Lambotte O, Venet A, Pancino G, ANRS EP36 HIV Controllers Study Group.
    J Immunol; 2009 Jun 15; 182(12):7828-37. PubMed ID: 19494307
    [Abstract] [Full Text] [Related]

  • 12. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates.
    Wille-Reece U, Flynn BJ, Loré K, Koup RA, Kedl RM, Mattapallil JJ, Weiss WR, Roederer M, Seder RA.
    Proc Natl Acad Sci U S A; 2005 Oct 18; 102(42):15190-4. PubMed ID: 16219698
    [Abstract] [Full Text] [Related]

  • 13. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells.
    Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, Pantaleo G.
    Proc Natl Acad Sci U S A; 2005 May 17; 102(20):7239-44. PubMed ID: 15872023
    [Abstract] [Full Text] [Related]

  • 14. Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years.
    Lind A, Sommerfelt M, Holmberg JO, Baksaas I, Sørensen B, Kvale D.
    Scand J Infect Dis; 2012 Aug 17; 44(8):566-72. PubMed ID: 22339485
    [Abstract] [Full Text] [Related]

  • 15. Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers.
    Scott-Algara D, Buseyne F, Blanche S, Rouzioux C, Jouanne C, Romagné F, Rivière Y.
    J Infect Dis; 2001 Jun 01; 183(11):1565-73. PubMed ID: 11343205
    [Abstract] [Full Text] [Related]

  • 16. Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).
    Boström AC, Hejdeman B, Matsuda R, Fredriksson M, Fredriksson EL, Bratt G, Sandström E, Wahren B.
    Vaccine; 2004 Apr 16; 22(13-14):1683-91. PubMed ID: 15068851
    [Abstract] [Full Text] [Related]

  • 17. [Immunodominance in CD8+ T cell responses to HIV-1 synthesized epitopes].
    Tang YB, Tang XP, Jin X.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep 16; 21(3):217-9. PubMed ID: 17971925
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The frequency of HIV-specific interferon- gamma -producing CD8 T cells is associated with both age and level of antigenic stimulation in HIV-1-infected children.
    Buseyne F, Scott-Algara D, Bellal N, Burgard M, Rouzioux C, Blanche S, Riviere Y.
    J Infect Dis; 2005 Nov 15; 192(10):1781-6. PubMed ID: 16235177
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
    Zhang Z, Zhao QX, Fu JL, Yao JX, He Y, Jin L, Wang FS.
    Chin Med J (Engl); 2006 Dec 05; 119(23):1949-57. PubMed ID: 17199938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.